NO941365L - Azabicyklo-arylacetylen- og -arylenyn-oksimer som cholinerge midler og fremgangsmåte for behandling - Google Patents
Azabicyklo-arylacetylen- og -arylenyn-oksimer som cholinerge midler og fremgangsmåte for behandlingInfo
- Publication number
- NO941365L NO941365L NO941365A NO941365A NO941365L NO 941365 L NO941365 L NO 941365L NO 941365 A NO941365 A NO 941365A NO 941365 A NO941365 A NO 941365A NO 941365 L NO941365 L NO 941365L
- Authority
- NO
- Norway
- Prior art keywords
- oxymers
- azabicycloaryl
- aryleneyn
- acetylene
- treatment
- Prior art date
Links
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 title 1
- 230000001713 cholinergic effect Effects 0.000 title 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 title 1
- 150000001412 amines Chemical group 0.000 abstract 2
- -1 nitrogen containing cyclic oxime Chemical group 0.000 abstract 2
- 150000002923 oximes Chemical class 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Carbon And Carbon Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/778,412 US5306718A (en) | 1990-03-06 | 1991-10-16 | Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment |
| PCT/US1992/008642 WO1993008192A1 (en) | 1991-10-16 | 1992-10-09 | Azabicyclo arylacetylene and arylenyne oximes as cholinergic agents and methods of treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO941365L true NO941365L (no) | 1994-04-15 |
| NO941365D0 NO941365D0 (no) | 1994-04-15 |
| NO302072B1 NO302072B1 (no) | 1998-01-19 |
Family
ID=25113261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941365A NO302072B1 (no) | 1991-10-16 | 1994-04-15 | Azabicyklo-arylacetylen- og -arylenyn-oksimer som cholinerge midler og preparater inneholdende slike |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5306718A (no) |
| EP (1) | EP0608336B1 (no) |
| JP (1) | JP3367670B2 (no) |
| KR (1) | KR100241479B1 (no) |
| AT (1) | ATE166354T1 (no) |
| AU (1) | AU658685B2 (no) |
| CA (1) | CA2115443C (no) |
| DE (1) | DE69225601T2 (no) |
| DK (1) | DK0608336T3 (no) |
| ES (1) | ES2119823T3 (no) |
| FI (1) | FI106797B (no) |
| NO (1) | NO302072B1 (no) |
| NZ (1) | NZ244726A (no) |
| PH (1) | PH31431A (no) |
| PT (1) | PT100961B (no) |
| WO (1) | WO1993008192A1 (no) |
| ZA (1) | ZA927973B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5346911A (en) * | 1990-03-06 | 1994-09-13 | Warner-Lambert Company | Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment |
| US5514812A (en) * | 1994-06-10 | 1996-05-07 | Warner-Lambert Company | Preparation of stereochemically pure oximes with muscarinic activity |
| AUPM910994A0 (en) * | 1994-10-28 | 1994-11-24 | Commonwealth Scientific And Industrial Research Organisation | Bisallyloxyimides |
| US5534522A (en) * | 1995-06-07 | 1996-07-09 | Warner-Lambert Company | (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent |
| US6168912B1 (en) | 1996-01-23 | 2001-01-02 | Martek Biosciences Corporation | Method and kit for making a multidimensional combinatorial chemical library |
| CA2270884A1 (en) * | 1997-01-27 | 1998-07-30 | Haile Tecle | Single pot process for producing (z)-azabicyclo oxime ethers |
| US6924313B1 (en) | 1999-09-23 | 2005-08-02 | Pfizer Inc. | Substituted tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| US6544974B2 (en) * | 1999-09-23 | 2003-04-08 | G.D. Searle & Co. | (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
| KR100465277B1 (ko) * | 2002-01-24 | 2005-01-13 | 한국과학기술연구원 | 신규한 옥심계 아자 두 고리 화합물 및 그 제조방법 |
| CN102379684B (zh) | 2005-04-28 | 2014-11-19 | 普罗透斯数字保健公司 | 药物信息系统 |
| KR20090071598A (ko) | 2006-09-18 | 2009-07-01 | 랩터 파마슈티컬 인코포레이티드 | 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료 |
| EP2398500B1 (en) | 2009-02-20 | 2019-03-13 | 2-BBB Medicines B.V. | Glutathione-based drug delivery system |
| ES2942923T3 (es) | 2009-05-06 | 2023-06-07 | Laboratory Skin Care Inc | Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3381012A (en) * | 1961-08-08 | 1968-04-30 | Sterling Drug Inc | Primary, secondary, and tertiary-(1-piperidyl)-lower-alkylamines |
| US3502692A (en) * | 1962-06-13 | 1970-03-24 | American Cyanamid Co | Cyclic nitroxides and process for preparing same |
| DE2019536A1 (de) * | 1970-04-23 | 1971-11-11 | Basf Ag | Oximcarbamate |
| DE2552176A1 (de) * | 1975-11-21 | 1977-06-02 | Hoechst Ag | Neue piperidin-derivate, ihre herstellung und verwendung |
| US4341795A (en) * | 1975-12-01 | 1982-07-27 | Union Carbide Corporation | Asymmetrical bis-carbamate compounds |
| US4710508A (en) * | 1986-12-08 | 1987-12-01 | Warner-Lambert Company | O-substituted tetrahydropyridine oxime cholinergic agents |
| NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
| US4937239A (en) * | 1989-02-13 | 1990-06-26 | Warner-Lambert Company | Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents |
| IL97266A0 (en) * | 1990-03-06 | 1992-05-25 | Warner Lambert Co | Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them |
-
1991
- 1991-10-16 US US07/778,412 patent/US5306718A/en not_active Expired - Fee Related
-
1992
- 1992-10-09 JP JP50773793A patent/JP3367670B2/ja not_active Expired - Fee Related
- 1992-10-09 DK DK92921974T patent/DK0608336T3/da active
- 1992-10-09 AU AU27835/92A patent/AU658685B2/en not_active Ceased
- 1992-10-09 KR KR1019940701231A patent/KR100241479B1/ko not_active Expired - Fee Related
- 1992-10-09 EP EP92921974A patent/EP0608336B1/en not_active Expired - Lifetime
- 1992-10-09 ES ES92921974T patent/ES2119823T3/es not_active Expired - Lifetime
- 1992-10-09 WO PCT/US1992/008642 patent/WO1993008192A1/en not_active Ceased
- 1992-10-09 CA CA002115443A patent/CA2115443C/en not_active Expired - Fee Related
- 1992-10-09 AT AT92921974T patent/ATE166354T1/de not_active IP Right Cessation
- 1992-10-09 DE DE69225601T patent/DE69225601T2/de not_active Expired - Fee Related
- 1992-10-14 PH PH45704A patent/PH31431A/en unknown
- 1992-10-14 NZ NZ244726A patent/NZ244726A/en unknown
- 1992-10-15 ZA ZA927973A patent/ZA927973B/xx unknown
- 1992-10-15 PT PT100961A patent/PT100961B/pt active IP Right Grant
-
1994
- 1994-02-01 US US08/189,620 patent/US5482938A/en not_active Expired - Fee Related
- 1994-04-13 FI FI941699A patent/FI106797B/fi active
- 1994-04-15 NO NO941365A patent/NO302072B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT100961A (pt) | 1993-11-30 |
| CA2115443A1 (en) | 1993-04-29 |
| EP0608336A1 (en) | 1994-08-03 |
| ES2119823T3 (es) | 1998-10-16 |
| CA2115443C (en) | 2003-05-13 |
| FI106797B (fi) | 2001-04-12 |
| KR100241479B1 (ko) | 2000-03-02 |
| NO941365D0 (no) | 1994-04-15 |
| DK0608336T3 (da) | 1999-01-18 |
| DE69225601D1 (de) | 1998-06-25 |
| JP3367670B2 (ja) | 2003-01-14 |
| EP0608336B1 (en) | 1998-05-20 |
| FI941699L (fi) | 1994-04-13 |
| ZA927973B (en) | 1994-04-15 |
| DE69225601T2 (de) | 1998-12-17 |
| FI941699A0 (fi) | 1994-04-13 |
| PT100961B (pt) | 1999-07-30 |
| NO302072B1 (no) | 1998-01-19 |
| US5306718A (en) | 1994-04-26 |
| PH31431A (en) | 1998-11-03 |
| NZ244726A (en) | 1995-09-26 |
| AU658685B2 (en) | 1995-04-27 |
| WO1993008192A1 (en) | 1993-04-29 |
| US5482938A (en) | 1996-01-09 |
| AU2783592A (en) | 1993-05-21 |
| ATE166354T1 (de) | 1998-06-15 |
| JPH07500337A (ja) | 1995-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2037541A1 (en) | Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment | |
| NO941365D0 (no) | Azabicyklo-arylacetylen- og -arylenyn-oksimer som cholinerge midler og fremgangsmåte for behandling | |
| CA2155104A1 (en) | Heterocyclic-substituted alkyl amide acat inhibitors | |
| ZA947970B (en) | Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases | |
| ATE217635T1 (de) | Zyklische peptide mit antifungischer wirkung und verfahren zu ihrer herstellung | |
| NZ238181A (en) | N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions | |
| TW341565B (en) | Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them | |
| PL298717A1 (en) | Cyclic imine derivatives, method of obtaining them and therapeutic agents containing such compounds | |
| MY123467A (en) | Preparation of sterically hindered amine ethers | |
| GB8819024D0 (en) | Chemical compounds | |
| DE69433148D1 (de) | Tricyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz | |
| DE69427517D1 (de) | Tetracyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz | |
| DK0677116T3 (da) | Fremgangsmåde til fremstilling af immunosuppressive midler og en ny mikroorganismeart til anvendelse deri | |
| MY108681A (en) | Derivatives of substituted imidazol-2-one and process for their preparation. | |
| TW333532B (en) | Benzopyrans | |
| MY108849A (en) | Novel compound | |
| EA199900684A1 (ru) | Производные иминоазаантрациклинона для лечения амилоидоза | |
| HUT72897A (en) | Indole derivatives having antitumor activity and pharmaceutical composition containing them | |
| DE3770433D1 (de) | 4-oxo-1,3-benzodioxan-derivat. | |
| EA200200574A1 (ru) | НОВЫЕ ЦИКЛИЧЕСКИЕ α-АМИНО-γ-ГИДРОКСИАМИДНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ | |
| ES2056025A1 (es) | Nuevos derivados de indol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |